NCT03717792 Vascular Liver Disease Evaluation, Follow Up and Non-Invasive Diagnostics Program
| NCT ID | NCT03717792 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Bonn |
| Condition | Vascular Disorder of Liver |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2010-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2010-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background Vascular liver disorders (VALDI) are rare diseases, for which knowledge on risk factors, appropriate methods of diagnosis, effect of therapy and prognosis still need to be improved. Aim of the study This project aims to study risk factors, methods of detection, therapy and prognosis in order to elaborate and disseminate updated recommendations for the optimal management of patients with VALDI. Design of the study Data on patients will be collected from baseline (the date of diagnosis) up to 3 years. During this period, data on clinical condition, laboratory results, diagnostic tests, interventions and outcome will be collected anonymously using standardised review of medical charts by one special trained investigator. Only patients with VALDI are eligible to participate.
Eligibility Criteria
Inclusion Criteria: * all patients with vascular liver disease Exclusion Criteria: * patients without vascular liver disease
Contact & Investigator
Michael Praktiknjo, MD
PRINCIPAL INVESTIGATOR
University of Bonn
Frequently Asked Questions
Who can join the NCT03717792 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Vascular Disorder of Liver. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03717792 currently recruiting?
Yes, NCT03717792 is actively recruiting participants. Contact the research team at michael.praktiknjo@ukbonn.de for enrollment information.
Where is the NCT03717792 trial being conducted?
This trial is being conducted at Bonn, Germany.
Who is sponsoring the NCT03717792 clinical trial?
NCT03717792 is sponsored by University Hospital, Bonn. The principal investigator is Michael Praktiknjo, MD at University of Bonn. The trial plans to enroll 500 participants.